The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 91.50
Bid: 88.00
Ask: 95.00
Change: 0.00 (0.00%)
Spread: 7.00 (7.955%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 91.50
UAV Live PriceLast checked at -
Unicorn AIM VCT is an Investment Trust

To provide shareholders with an attractive return from a diversified portfolio, predominantly invested in the shares of AIM quoted companies by maintaining dividend distributions to shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

23 Jul 2021 15:21

RNS Number : 3444G
Unicorn AIM VCT PLC
23 July 2021
 

 

Unicorn AIM VCT plc ("the Company")

Interim Management Statement 

For the period from 1 April 2021 to 30 June 2021

 

Introduction

 

This voluntary Interim Management Statement (IMS) covers the three month period ended 30 June 2021, together with relevant information up to the date of publication. 

 

Investment Objective

 

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust ("VCT"), so that Shareholders benefit from the taxation advantages that this brings. To achieve this, at least 80% for accounting periods commencing on or after 6 April 2019 (previously 70%) of the Company's total assets are to be invested in qualifying investments of which 70% by VCT value (30% in respect of investments made before 6 April 2018 from funds raised before 6 April 2011) must be in ordinary shares, which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance  

The Company's portfolio of investments performed reasonably well with net asset value per share continuing to increase steadily over the quarter.

As at 30 June 2021, the unaudited net asset value was 247.6 pence per share, which represents an increase of +6.7% on the audited closing net asset value of 232.1 pence per share as at 31 March 2021. UK equity indices also continued their strong run, with the FTSE AIM All-Share Index generating a total return of +4.5%, while the FTSE All-Share Index delivered a total return of +5.6% over the same period.

The portfolio remains predominantly composed of investments in businesses listed on the Alternative Investment Market (AIM). A good number of these investee companies are relatively mature and, as such, most of these businesses have remained profitable, despite the difficulties posed by the ongoing COVID-19 pandemic.

The number and value of new VCT qualifying investments completed in the period was healthy and the pipeline of promising opportunities continues to strengthen. As a result, all key HMRC tests continue to be met. At the period end, an estimated 86.6% of total assets (assessed in accordance with VCT rules) was invested in VCT qualifying companies.

Despite the increased risks associated with early stage investment and the uncertainty created by the COVID-19 pandemic, the Investment Manager is confident that the portfolio, as a whole, has the potential to continue delivering attractive total returns over the longer term.

 

Material Transactions

During the period under review, four new VCT qualifying investments were completed, costing £9.2 million in total. One follow-on VCT qualifying investment was also made at a total cost of £0.5m.

Approximately £0.3 million was raised from the partial disposal of two holdings during the period. In addition, the Company's entire holding in Wey Education was sold, following a successful takeover bid from Inspired Education Group. This disposal realised proceeds of over £4.6 million and a capital profit of almost £2.5 million.

The purpose of disposals is threefold; to ensure stock specific risk is contained, to lock in capital profits for future distribution to Shareholders via dividend payments, and to help manage liquidity requirements.

Top Ten VCT Qualifying Holdings as at 30 June 2021

Stock

% of fund

 

 

Interactive Investor

10.2%

Hasgrove

9.1%

Maxcyte

6.0%

Abcam

4.4%

Tracsis

4.1%

Renalytix AI

3.5%

Anpario

3.2%

Surface Transforms

3.0%

Tristel

2.8%

Augean

2.4%

 

 

Total

48.7%

 

Share Buy-Backs

 

During the period from 1 April to 30 June 2021, the Company bought back 592,273 of its own Ordinary Shares for cancellation, at a price of 210 pence per share. As at 30 June 2021, there were 149,758,626 Ordinary Shares in issue. After the period end, a further 293,191 Ordinary Shares were purchased for cancellation at a price of 215 pence per share.

 

Interim Dividend

As previously advised, the Board declared an interim dividend of 3.0 pence per share in respect of the Company's half year ended 31 March 2021. This interim dividend will be paid on 12 August 2021 to Shareholders who were on the register on 15 July 2021.

Issue of Equity

 

During the period, a total of 1,129,286 new Ordinary Shares were issued in the new tax year at prices ranging between 237.4p and 238.2p per share under the Offer for Subscription, which launched on 28 January 2021. The Offer closed on 11 February 2021 having raised approximately £15 million before costs.

Material Events

There were no material events during the period under review.

Chris Hutchinson

Director, Unicorn Asset Management

Investment Manager

 

23 July 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRMZGZNDFRGMZM
Date   Source Headline
8th Apr 20241:46 pmRNSNet Asset Value(s)
2nd Apr 202410:46 amRNSTotal Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 202412:00 pmRNSDirector/PDMR Shareholding
11th Mar 202411:59 amRNSTotal Voting Rights
11th Mar 202411:57 amRNSIssue of Equity
7th Mar 202411:34 amRNSNet Asset Value(s)
1st Mar 202410:54 amRNSTotal Voting Rights
15th Feb 20244:30 pmRNSOffer for Subscription Update
14th Feb 20241:36 pmRNSDirector/PDMR Shareholding
14th Feb 202410:23 amRNSIssue of Equity
8th Feb 20243:47 pmRNSOffer for Subscription - Update
7th Feb 20245:43 pmRNSResult of AGM
5th Feb 20243:37 pmRNSNet Asset Value(s)
1st Feb 20242:53 pmRNSInterim Management Statement
26th Jan 202411:47 amRNSOffer for Subscription and Issue of Prospectus
11th Jan 20247:00 amRNSDividend Declaration
9th Jan 202410:39 amRNSNet Asset Value(s)
20th Dec 20233:06 pmRNSDirector Declaration
8th Dec 20237:00 amRNSFinal Results
6th Dec 20233:47 pmRNSNet Asset Value(s)
28th Nov 202310:00 amRNSIntention to launch an Offer
6th Nov 20234:48 pmRNSNet Asset Value(s)
17th Oct 20235:04 pmRNSNet Asset Value(s)
2nd Oct 20239:19 amRNSTotal Voting Rights
25th Sep 20239:18 amRNSTransaction in Own Shares
7th Sep 202311:40 amRNSNet Asset Value(s)
1st Sep 202311:39 amRNSTotal Voting Rights
25th Aug 20239:16 amRNSTransaction in Own Shares
14th Aug 202312:42 pmRNSDirector/PDMR Shareholding
11th Aug 20231:47 pmRNSIssue of Equity under Dividend Reinvestment Scheme
4th Aug 202310:57 amRNSNet Asset Value(s)
1st Aug 202310:19 amRNSTotal Voting Rights
19th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20239:12 amRNSNet Asset Value(s)
3rd Jul 202312:23 pmRNSTotal Voting Rights
9th Jun 20234:11 pmRNSTransaction in Own Shares
6th Jun 20232:18 pmRNSHolding(s) in Company
5th Jun 20234:43 pmRNSNet Asset Value(s)
31st May 20237:00 amRNSHalf-year Report
5th May 20239:20 amRNSNet Asset Value(s)
6th Apr 202310:53 amRNSNet Asset Value(s)
3rd Apr 202310:25 amRNSTotal Voting Rights
10th Mar 20234:32 pmRNSTransaction in Own Shares
3rd Mar 20235:36 pmRNSNet Asset Value(s)
1st Mar 20239:52 amRNSTotal Voting Rights
22nd Feb 20234:04 pmRNSDirector/PDMR Shareholding
22nd Feb 20239:14 amRNSIssue of Equity
21st Feb 202311:43 amRNSNet Asset Value(s)
14th Feb 202312:42 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.